Harrow (HROW) Price to Sales (2013 - 2026)
Harrow (HROW) posted Price to Sales of 22.53 for Q2 2026, down 24.22% on a QoQ basis from 29.73 in Q1 2026, and up 28.08% year-over-year from 17.59 in Q2 2025.
Analysis
Harrow (HROW) Price to Sales (2013 - 2026) Analysis & Trends
Harrow has reported Price to Sales for 14 years, with the latest figure at 22.53 in Q2 2026.
- On a quarterly basis, Price to Sales rose 28.08% year-over-year to 22.53 in Q2 2026; TTM through Jun 2026 was 5.78, a 17.28% increase from a year earlier, with the FY2025 full-year figure at 6.7, up 11.89% from the prior year.
- Price to Sales was 22.53 for Q2 2026 at Harrow, down from 29.73 in the prior quarter.
- The five-year high for Price to Sales was 32.5 in Q3 2024, with the low at 8.33 in Q1 2022.
- Average Price to Sales over 5 years is 18.56, with a median of 17.74 recorded in 2024.
- The largest YoY upside for Price to Sales was 192.35% in 2023 against a maximum downside of 50.1% in 2023.
- Over 5 years, Price to Sales stood at 21.71 in 2022, then plunged by 50.1% to 10.83 in 2023, then soared by 65.06% to 17.88 in 2024, then gained by 14.5% to 20.48 in 2025, then increased by 10.03% to 22.53 in 2026.
- The last three Price to Sales figures came in at 22.53 (Q2 2026), 29.73 (Q1 2026), and 20.48 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Harrow | 1.42 Bn | 1.33 Bn | 50.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.53 |
| Mar 31, 2026 | 29.73 |
| Dec 31, 2025 | 20.48 |
| Sep 30, 2025 | 24.91 |
| Jun 30, 2025 | 17.59 |
| Mar 31, 2025 | 19.83 |
| Dec 31, 2024 | 17.88 |
| Sep 30, 2024 | 32.50 |
| Jun 30, 2024 | 15.14 |
| Mar 31, 2024 | 13.53 |
| Dec 31, 2023 | 10.83 |
| Sep 30, 2023 | 14.73 |
| Jun 30, 2023 | 17.22 |
| Mar 31, 2023 | 24.36 |
| Dec 31, 2022 | 21.71 |
| Sep 30, 2022 | 14.32 |
| Jun 30, 2022 | 8.45 |
| Mar 31, 2022 | 8.33 |
| Dec 31, 2021 | 11.51 |
| Sep 30, 2021 | 13.07 |